⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2012ChemotherapyOpen Access

Risk and Healthcare Costs of Chemotherapy-Induced Neutropenic Complications in Women with Metastatic Breast Cancer

Derek Weycker John Edelsberg Alex Kartashov Rich Barron Gary H. Lyman

View Full Paper

Ask AI

Bookmark

Share

Abstract

CINC is a clinically and economically important threat among women with MBC, and should be an important consideration in the treatment of this population.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Weycker et al. (2012) studied this question.

synapsesocial.com/papers/69deac936bae133e7de949b6 https://doi.org/10.1159/000335604

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Cerebrospinal fluid penetration of new antibiotics in the treatment of central nervous system infectionsChemotherapy · Tue,
2Therapeutic Drug Monitoring of Linezolid in Real-World Clinical Practice: Determinants of Exposure, Dose Optimization and Hematological ToxicityChemotherapy · Thu,
3Beyond Conventional Monoclonals: Novel Antibody Formats and Derivatives as the Next Frontier in Cancer TherapyChemotherapy · Mon,
4Pseudoprogression of a head and neck cutaneous squamous cell carcinoma treated with anti-PD-1 immunotherapy: a case report and review of the literatureChemotherapy · Fri,
5Clinical Feasibility of Platinum-Based Chemotherapy Followed by Avelumab Maintenance after Enfortumab Vedotin plus Pembrolizumab in Metastatic Urothelial Carcinoma: A case seriesChemotherapy · Thu,

More from Chemotherapy

Efficacy and safety study of different doses of linezolid in combination with bedaquiline in the treatment of drug-resistant pulmonary tuberculosisWed,
Can Model-Informed Precision Dosing of Beta-Lactams in Critical Care Improve Clinical Outcomes?Tue,
Drug-Drug Interaction between Toosendanin and Tamoxifen and Its Potential MechanismTue,
Epiploic Appendagitis in a Breast Cancer Patient on Abemaciclib: Case ReportWed,
Role of a TDM-guided strategy of isavuconazole for optimizing efficacy/safety outcomes in onco-hematological pediatric patients: a systematic reviewTue,